David Dawbarn

University of Bristol, Bristol, England, United Kingdom 
NGF, Alzheimer's, pain
"David Dawbarn"
Mean distance: 18.78 (cluster 32)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shoemark DK, Williams C, Fahey MS, et al. (2015) Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. Journal of Medicinal Chemistry. 58: 767-77
Frias B, Allen S, Dawbarn D, et al. (2013) Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience. 234: 88-102
Allen SJ, Watson JJ, Dawbarn D. (2011) The neurotrophins and their role in Alzheimer's disease. Current Neuropharmacology. 9: 559-73
Cristofaro B, Stone OA, Caporali A, et al. (2010) Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 1143-50
McNamee KE, Burleigh A, Gompels LL, et al. (2010) Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain. 149: 386-92
Pinto R, Frias B, Allen S, et al. (2010) Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience. 166: 907-16
Masoudi R, Ioannou MS, Coughlin MD, et al. (2009) Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. The Journal of Biological Chemistry. 284: 18424-33
Lu VB, Biggs JE, Stebbing MJ, et al. (2009) Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. The Journal of Physiology. 587: 1013-32
Watson JJ, Allen SJ, Dawbarn D. (2008) Targeting nerve growth factor in pain: what is the therapeutic potential? Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 22: 349-59
Clewes O, Fahey MS, Tyler SJ, et al. (2008) Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin. Journal of Neurochemistry. 107: 1124-35
See more...